Coherus Biosciences | CHRS - ДОЛГ





ДОЛГ Изменить Дата
AbbVie USD 72.86B 5.36B 2026-03
Acadia Pharmaceuticals USD 50.79M 1.39M 2026-03
Akebia Therapeutics USD 46.51M 7.82M 2025-03
ALKERMES USD 1.58B 1.51B 2026-03
Alnylam Pharmaceuticals USD 1.27B 5.33M 2026-03
Amarin USD 0 0 2025-03
Amgen USD 57.32B 2.72B 2026-03
Baxter International USD 9.69B 93M 2026-03
Biogen USD 8.09B 1.53B 2026-06
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eli Lilly USD 43.37B 867M 2026-03
Fujifilm JPY 1.03T 104.2B 2026-03
Gilead Sciences USD 22.17B 2.76B 2026-03
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Merck USD 49.12B 222M 2026-03
Myriad Genetics USD 59.3M 19.7M 2025-03
Pacira USD 363.12M 4.53M 2026-06
Perrigo USD 3.63B 7.7M 2026-03
Pfizer USD 63.19B 536M 2026-06
PTC Therapeutics USD 286.94M 2.42B 2026-03
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
Teva Pharmaceutical Industries USD 16.91B 187M 2026-03
Vertex Pharmaceuticals USD 1.98B 8.9M 2026-06
Xencor USD 175.16M 12.58M 2026-03
Zoetis USD 9.24B 0 2026-03